Company market cap and ETF fund assets are separate measures, shown in USD. A dash means unavailable or not applicable. Hover over a value for its source and dates.Expand listing details for sources and dates. Corporate valuation ratios are omitted for ETFs.
| Ticker | ISIN | Type | Sector | Industry | Exchange | Country | Currency | Yield (%) | Yield 1Y (%) | Yield 3Y (%) | Yield 5Y (%) | Yield 10Y (%) | Dividend CAGR 1Y (%) | Dividend CAGR 3Y (%) | Dividend CAGR 5Y (%) | Growth Streak | Freq | P/E | Payout (%) | EPS | Market cap (USD) | Fund assets / AUM (USD) | Book | P/B | Beta | Next Earnings | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() VRTX Vertex Pharmaceuticals Incorporated Common Stock | US92532F1003 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 32.47 | 0.0% | 14.21 | 118.68B | — | 68.197 | 6.79 | 0.16611972 | 2026-11-02 | ||||||
![]() REGN Regeneron Pharmaceuticals, Inc. | US75886F1075 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.47 | 0.46 | 0.00 | 0.00 | 0.00 | Quarterly | 18.60 | 9.2% | 41.69 | 83.06B | — | 301.146 | 2.60 | -0.54136503 | 2026-10-30 | |||||
![]() ALNY Alnylam Pharmaceuticals, Inc. | US02043Q1076 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 1245.94 | 0.0% | 0.32 | 52.67B | — | 1.775 | 224.62 | 0.082358614 | 2026-10-29 | ||||||
![]() ARGX argenx SE American Depositary Receipt | US04016X1019 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 36.11 | 0.0% | 23.4 | 52.62B | — | 99.659 | 8.48 | 0.7269855 | 2027-02-25 | ||||||
![]() INSM Insmed Incorporated | US4576693075 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -6.19 | 37.84B | — | 4.448 | 39.89 | -0.37026904 | 2026-10-29 | ||||||
![]() ONC BeOne Medicines Ltd. American Depositary Shares | US07725L1026 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 67.00 | 0.0% | 0.53 | 34.57B | — | 37.328 | 8.37 | 0.55402515 | 2026-11-05 | ||||||
![]() RPRX Royalty Pharma plc | GB00BMVP7Y09 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 1.63 | 1.57 | 1.49 | 1.42 | 5.81 | 0.00 | 0.00 | Quarterly | 31.00 | 50.4% | 1.74 | 22.89B | — | 14.951 | 2.63 | -0.41208805 | N/A | |||
![]() BNTX BioNTech SE | US09075V1026 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -2.82 | 22.73B | — | 90.45958 | 1.04 | 1.309 | N/A | ||||||
![]() GMAB Genmab A/S American Depositary Shares | DK0010272202 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 25.46 | 0.0% | 2.28 | 20.72B | — | 93.41 | 0.36 | -0.49199927 | N/A | ||||||
![]() INCY Incyte Corporation | US45337C1027 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 16.28 | 0.0% | 5.9 | 19.72B | — | 23.715 | 4.24 | 0.815 | N/A |
Example security pages for checking stock price, dividend, exchange, ISIN, and CUSIP data after screening.